Medical Licensing (MD/DO) · Independent exam preparation
ABPS Oral Examination: 2026 Clinical Reasoning Guide Study Guide
Practise operative planning, urgent complication recognition, outcome analysis, informed consent, and clear case defense for the 2026 ABPS Oral Examination.
By CertMedbry · Updated 19 October 2026
Choose defensible operations, recognize threatened tissue, explain alternatives, and analyse outcomes through 60 focused concepts. Each connects a clinical principle to a decision you can defend aloud. This selective guide addresses all eight oral assessment domains; the official ABPS outline, applicable handbook, and examination guidance define the full scope of preparation.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
Which certification examination does this guide address?
This guide addresses the American Board of Plastic Surgery, Inc. Oral Examination, a component of initial specialty board certification. It is distinct from medical licensure, the ABPS Written Examination, the Hand Surgery Examination, and Continuous Certification. Oral admissibility requires successful completion of the Written Examination and an acceptable operative case list.
ABPS: Overview of Oral Exam · ABPS: Publications & Requirements
How many cases are selected, and what happens if documentation is deficient?
ABPS selects five cases from an acceptable candidate case list. The cited materials do not publish a fixed total number of oral questions or a scored-versus-pretest count. For the 2026 cohort, candidates lacking postoperative photographs at least 90 days after surgery are encouraged to locate the patient and attempt to obtain them before contacting the Board about the deficiency. Notification of incomplete case-report documentation results in three additional assigned cases; that assignment remains final even if the original documentation is later completed. The handbook gives August 17, 2026 as the last date to request additional cases and August 20, 2026 at 12:00 p.m. EST as the finalization deadline for all cases. Written reports cannot substitute for mandatory intraoperative photographs.
ABPS: Overview of Oral Exam · ABPS 2025–2026 Booklet of Information: Oral Examination Section
What are the duration and delivery format?
The examination comprises one Case Report session and two Theory and Practice sessions, each lasting 45 minutes. These are examiner-led oral sessions. ABPS describes an examination event occupying two and one-half days, with individual examination sessions occurring over two days.
Which handbook applies to the 2026 examination?
The 2025–2026 Booklet of Information applies to examinations taken in 2026, including the Oral Examination scheduled November 12–14, 2026. Its posted oral-section filename identifies a January 14, 2026 page-43 update; that filename does not establish a separate examination-wide effective date. The newer 2026–2027 booklet applies to the 2027 cohort and schedules its oral examination for November 11–13, 2027.
ABPS: Publications & Requirements · ABPS 2025–2026 Booklet of Information: Oral Examination Section · ABPS Booklet of Information: July 1, 2026–June 30, 2027
Are oral domain percentage weights published?
The oral assessment section states no percentage weights. This guide uses the combined Theory and Practice and Case Report assessment domains, with editorial emphasis on clinical decisions and complications. Written Examination percentage blueprints are not applied to the oral examination. Clinical topics within the domains are selective teaching mappings, and their allocation does not represent issuer weights.
ABPS 2025–2026 Booklet of Information: Oral Examination Section · ABPS: Preparation for Examinations
What determines the result?
ABPS evaluates combined performance across the oral sessions, including reasoning, treatment choices, complication management, safety, professionalism, and case preparation. The cited oral assessment evidence does not establish a numerical passing score. A percentage correct on these independent drills cannot predict an ABPS result.
ABPS 2025–2026 Booklet of Information: Oral Examination Section · ABPS: Preparation for Examinations
How should the multiple-choice questions be used?
The 20 original four-option questions practise identifying decisive findings and defending a management choice. They do not reproduce oral delivery or secure examination content. After choosing an answer, explain the reasoning aloud, reject each alternative, and state what additional finding would change your plan.
Independently authored preparation for the American Board of Plastic Surgery initial certification Oral Examination, centred on the 2026 cohort. Clinical references support the teaching recommendations; ABPS materials establish assessment scope. These learning materials are neither official ABPS items nor endorsed by ABPS.
Outline used: 2026 Oral Examination: official 2025–2026 Booklet of Information, Oral Examination section, with posted filename identifying a page-43 update dated 2026-01-14. The latest posted 2026–2027 booklet is dated July 1, 2026–June 30, 2027 and applies to the 2027 examination. Both were inspected; the 2026 oral assessment criteria provide the principal mapping here. Verified as of 2026-10-10.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
Diagnosis/Planningnot stated
1.How should a suspicious pigmented lesion be sampled?
The diagnostic specimen must establish whether melanoma is present and permit microstaging. Local excision is preferred when feasible because preserving the lesion's architecture and depth supports interpretation. Destructive treatment can eliminate the tissue needed to determine invasion. Definitive excision and discussion of nodal staging depend on pathological findings, so a convenient cosmetic removal should not replace an adequate diagnostic procedure.
Apply it
An enlarging irregular pigmented lesion on the upper arm is suitable for diagnostic excision. Choose tissue-preserving excision over requested cautery because invasion must be measured. A location or size preventing straightforward complete sampling would change the biopsy plan.
Common pitfall: A visually complete removal does not establish adequate pathological assessment or definitive melanoma treatment. Destroying the lesion can permanently remove essential staging information.
National Cancer Institute: Melanoma Treatment (PDQ), Health Professional Version
2.Why does melanoma thickness matter more than surface diameter?
Breslow thickness describes the depth of invasive melanoma and contributes directly to primary tumour classification, prognosis, excision planning, and consideration of sentinel-node biopsy. Surface diameter describes lateral extent but cannot substitute for invasive depth. A small lesion may therefore require more extensive oncologic planning than a larger, thinner lesion. Identify the measured thickness before defending margins or a regional staging strategy.
Apply it
Two patients have melanomas with similar surface diameters, but one measures 0.6 mm thick and the other 2.7 mm. Base the different excision and nodal-staging discussions on invasive depth rather than appearance.
Common pitfall: A narrow skin footprint can falsely suggest low risk. Do not infer biological behaviour or required margins from a photograph when microscopic invasion is known.
National Cancer Institute: Melanoma Treatment (PDQ), Health Professional Version
3.How does ulceration change classification of thin melanoma?
A cutaneous melanoma less than 0.8 mm thick without ulceration is T1a. A tumour less than 0.8 mm with ulceration, or 0.8–1.0 mm with or without ulceration, is T1b. Thickness alone therefore does not distinguish every thin melanoma category. Histological ulceration supplies a discriminating risk feature and can change the conversation about sentinel-node assessment even when the invasive measurement remains below 0.8 mm.
Apply it
A 0.7-mm ulcerated melanoma with clear diagnostic-biopsy margins is T1b. Proceed to definitive excision planning and discuss sentinel-node assessment. Without ulceration, the same thickness would be T1a.
Common pitfall: Calling every melanoma below 0.8 mm T1a ignores ulceration. Clear biopsy margins also do not establish that definitive treatment and staging decisions are complete.
National Cancer Institute: Melanoma Treatment (PDQ), Health Professional Version
4.When should sentinel-node assessment enter melanoma planning?
Sentinel lymph node biopsy evaluates clinically occult regional metastasis. NCI describes considering it for melanomas at least 0.8 mm thick and selected ulcerated lesions below that threshold. The decision incorporates tumour risk and whether staging information will affect care. Clinically negative nodes do not establish microscopic negativity. An already suspicious node creates a different diagnostic problem from elective sentinel-node staging in a clinically node-negative patient.
Apply it
For a 0.9-mm melanoma without palpable adenopathy, discuss sentinel-node biopsy alongside definitive primary treatment. A newly suspicious regional node would require directed diagnostic evaluation rather than assuming the patient remains clinically node-negative.
Common pitfall: Normal palpation cannot exclude microscopic nodal disease. Sentinel-node biopsy also should not be described as a guaranteed survival benefit or a substitute for primary excision.
National Cancer Institute: Melanoma Treatment (PDQ), Health Professional Version
5.When can carpal tunnel syndrome be diagnosed clinically?
AAOS supports using CTS-6 to diagnose carpal tunnel syndrome without routine ultrasound or electrodiagnostic confirmation. The clinical assessment integrates median-distribution numbness, nocturnal symptoms, thenar weakness or atrophy, sensory discrimination, and provocative findings. A coherent constellation carries more diagnostic meaning than one isolated positive manoeuvre. Diagnostic confidence and severity remain separate questions: confidence that symptoms arise from CTS does not automatically establish advanced nerve injury or an indication for immediate surgery.
Apply it
An adult has characteristic nocturnal median-territory numbness with concordant examination findings and no competing localization. A structured clinical assessment may support treatment discussion without automatically ordering confirmatory tests.
Common pitfall: A positive provocative test alone is insufficient. Do not treat a clinical diagnostic instrument as a severity scale or assume every symptom in the hand arises from CTS.
AAOS: Management of Carpal Tunnel Syndrome Evidence-Based Clinical Practice Guideline, 2024
6.Which diagnostic uncertainty justifies additional hand testing?
AAOS supports ultrasound or nerve-conduction and electromyographic testing when clinical diagnostic confidence is low. Ultrasound can assess the median nerve at the wrist; electrodiagnostic testing can address physiological localization. Separate confirmation of suspected CTS from investigation of another disorder, because a CTS assessment does not evaluate every cause of numbness. MRI is not recommended as a CTS diagnostic test, although another independently suspected condition may have a separate imaging indication.
Apply it
A patient has nocturnal numbness but incomplete or discordant examination findings. Select testing that resolves the actual uncertainty before release. Symptoms predominantly involving the little finger require consideration of another localization.
Common pitfall: An uncertain clinical assessment is not a negative diagnosis. Conversely, an abnormal median-nerve test does not automatically explain symptoms outside the median distribution.
AAOS: Management of Carpal Tunnel Syndrome Evidence-Based Clinical Practice Guideline, 2024
7.Which findings distinguish deeper burns?
Burn depth is assessed through appearance, moisture, blanching, and sensation together. Moist, blistered, blanching skin supports superficial partial-thickness injury. Increasing dryness, pallor, reduced blanching, and reduced sensation suggest greater depth. The decision follows the combined pattern rather than pain intensity alone. Document variation across the wound because one exposure can produce mixed depths, and explain how uncertainty about a potentially deep area changes consultation and reassessment.
Apply it
After a scald, one area is moist and very painful while an adjacent patch is pale, dry, and minimally sensitive. Record mixed-depth findings and give the less sensitive area particular attention.
Common pitfall: Less pain can reflect deeper injury rather than improvement. Calling the entire wound one depth because the exposure was uniform overlooks clinically important variation.
American Burn Association: Burn Patient Referral Guidelines, 2022
8.How should burn surface area be calculated?
Total body surface area calculations include partial- and full-thickness burns, while superficial erythema is excluded. Adult regional estimates and the patient's entire palmar surface, approximately 1%, provide different ways to estimate extent. State the method and depth included so the number can be interpreted. A reproducible calculation identifies each counted region, avoids double counting, and distinguishes uncertain depth from the numerical estimate.
Apply it
An adult has partial-thickness injury over the entire anterior trunk and superficial redness elsewhere. Count the anterior trunk as approximately 18% TBSA while documenting the excluded superficial areas separately.
Common pitfall: Adding every red area inflates burn size. Using the examiner's hand instead of the patient's hand introduces an avoidable error into small-area estimation.
American Burn Association: Burn Patient Referral Guidelines, 2022
9.How is pressure-ulcer osteomyelitis established?
A deep pressure ulcer raises concern for bone infection, but exposed bone or a positive wound swab does not establish osteomyelitis. WHS recommends bone biopsy for culture and histology when osteomyelitis is suspected. This distinction matters before prolonged treatment or reconstruction. Histology assesses infection within bone, while culture helps identify organisms relevant to targeted treatment. Surface microbiology samples a different environment and cannot answer both questions.
Apply it
A stable patient has a chronic sacral ulcer, exposed bone, and a mixed-organism surface swab. Choose bone histology and culture before definitive reconstruction. Systemic deterioration would require concurrent urgent treatment.
Common pitfall: Surface colonization is easy to sample but does not reliably establish the presence or microbiology of infection within underlying bone. Do not equate accessibility with diagnostic adequacy.
WHS Guidelines for the Treatment of Pressure Ulcers—2023 Update
10.Why does cleft care require continuing hearing assessment?
A passed newborn hearing screen establishes hearing status at one point rather than guaranteeing normal hearing throughout development. Children with cleft-related conditions require longitudinal assessment because later middle-ear dysfunction and hearing problems can affect communication. When speech development is concerning, evaluate hearing alongside speech production. Distinguish an auditory contribution from articulation or structural speech problems instead of assuming that every communication difficulty arises from the repaired palate.
Apply it
A child with repaired cleft palate passed newborn screening but now has delayed language and inconsistent responses to speech. Arrange audiological and otologic assessment while continuing the cleft team's speech evaluation.
Common pitfall: Reassurance based solely on newborn screening misses later problems. Speech therapy cannot compensate fully for an unrecognized hearing deficit that limits access to speech sounds.
Management/Treatmentnot stated
11.How are margins chosen for thinner invasive melanoma?
Definitive melanoma excision uses a clinical radial margin guided by invasive thickness and patient factors rather than the diagnostic incision alone. For a melanoma measuring between 1 and 2 mm, a 1–2 cm margin can be considered within the NCI treatment framework. State the thickness, selected margin, and functional or cosmetic considerations. Reconstruction should accommodate an oncologically defensible defect rather than determine the excision boundary in advance.
Apply it
For a 1.4-mm melanoma near a functionally important area, explain a 1-cm clinical margin within the supported range before selecting coverage. A revised thickness above 2 mm changes the margin discussion.
Common pitfall: Choosing the smallest defect solely to simplify closure reverses the planning sequence. An elegant reconstruction cannot justify an inadequately reasoned oncologic excision.
National Cancer Institute: Melanoma Treatment (PDQ), Health Professional Version
12.What margin principle applies to melanoma thicker than 2 mm?
For localized cutaneous melanoma thicker than 2 mm, a 2-cm clinical radial excision margin is supported in the NCI treatment summary. Increasing the margin beyond this should not be assumed to improve survival or local control. Separate the evidence-supported oncologic boundary from its reconstructive consequences. A larger graft or flap requirement is a treatment burden to discuss, rather than evidence that a still wider excision is inherently better.
Apply it
A patient has a localized 3.2-mm melanoma on the trunk. Plan a 2-cm clinical radial margin and explain why a proposed 4-cm margin would enlarge the defect without an established corresponding benefit.
Common pitfall: More tissue removal can feel safer while adding morbidity. Do not equate a wider defect with superior cancer treatment when comparative evidence does not support it.
National Cancer Institute: Melanoma Treatment (PDQ), Health Professional Version
13.Why does a positive sentinel node require a new treatment discussion?
A positive sentinel node demonstrates regional metastatic disease and changes prognosis and subsequent management discussions. It does not automatically make completion lymph-node dissection the only appropriate next step. NCI describes regional ultrasound surveillance and adjuvant treatment considerations for clinically occult nodal metastases. Explain the new disease state and coordinate multidisciplinary review, separating the goal of regional control from the potential benefits and burdens of systemic treatment.
Apply it
After primary melanoma excision, sentinel-node pathology is positive. Explain the regional staging implication and arrange discussion of nodal surveillance and adjuvant options rather than promising an automatic completion dissection.
Common pitfall: Treating the result as another primary excision-margin problem misses its staging significance. Routine escalation to more surgery can bypass relevant surveillance and systemic options.
National Cancer Institute: Melanoma Treatment (PDQ), Health Professional Version
14.How should fixation and coverage be coordinated in an open fracture?
Skeletal stability and durable soft-tissue coverage form one reconstructive strategy. The UK BOASt open-fracture standard calls for concurrent orthopaedic and plastic surgical planning, linking definitive internal fixation to immediately following definitive coverage. Explain the sequence before committing to hardware placement. This source provides a jurisdiction-specific model of coordinated orthoplastic care; its timing standards should not be presented as universal legal requirements for every practice setting.
Apply it
An open tibial fracture requires fixation and flap coverage. Under the cited UK standard, proceed with definitive fixation when definitive coverage can immediately follow. Otherwise, revise the staged strategy jointly.
Common pitfall: Treating coverage as a later cosmetic task can leave definitive hardware without a coherent soft-tissue plan. Joint planning should precede irreversible reconstructive commitments.
15.Which factors belong in a limb-salvage decision?
Limb salvage requires assessment of anticipated function and rehabilitation as well as the ability to obtain coverage. BOASt describes multidisciplinary participation including orthopaedic surgery, plastic surgery, rehabilitation, and the patient and family or carers. A technically survivable limb is one outcome dimension. Explain the likely treatment course, burdens, and functional possibilities so the recommendation reflects the whole patient rather than one surgeon's ability to perform a flap.
Apply it
A severely injured lower limb would require repeated reconstruction with uncertain functional recovery. Present salvage and amputation through a joint surgical and rehabilitation discussion that includes the patient's priorities and available support.
Common pitfall: A successful flap is an intermediate technical result. It should not independently predict a useful limb or dismiss the burdens of prolonged rehabilitation.
16.When can local anaesthesia be used for carpal tunnel release?
The anaesthetic plan should match the operation, patient circumstances, and ability to tolerate the proposed approach. AAOS supports local anaesthesia alone for carpal tunnel release, so general anaesthesia is not an inherent requirement. Defend the choice by explaining how adequate operating conditions and patient comfort will be achieved. Include the supported local option in shared decision-making rather than omitting it because a different approach is routine.
Apply it
An adult requests awake isolated release and can cooperate and tolerate local injection. Select local anaesthesia alone after discussion. Inability to tolerate the awake procedure would change the anaesthetic plan.
Common pitfall: Routine use of general anaesthesia does not make it necessary. A supported local approach still requires assessment of individual suitability, comfort, and preferences.
AAOS: Management of Carpal Tunnel Syndrome Evidence-Based Clinical Practice Guideline, 2024
17.How should open and endoscopic carpal tunnel release be compared?
Choosing a release technique requires explaining the intended benefit without overstating comparative evidence. AAOS reports similar patient-reported outcomes for mini-open and endoscopic release. A defensible recommendation connects the approach to patient circumstances, surgeon expertise, and procedural discussion rather than claiming inevitable superior long-term results from a smaller incision. Separate the technique used to achieve decompression from the outcome the patient values, such as symptom relief or daily function.
Apply it
A patient requests endoscopic release because an advertisement promises better permanent results. Explain the comparative patient-reported outcome evidence and discuss an approach you can perform safely and justify for this patient.
Common pitfall: Incision size is an attractive surrogate for success. It does not establish superior long-term patient-reported outcomes or remove the need for individualized discussion.
AAOS: Management of Carpal Tunnel Syndrome Evidence-Based Clinical Practice Guideline, 2024
18.How should secondary velopharyngeal surgery be planned?
A secondary speech operation should address a demonstrated mechanism rather than a nonspecific description of nasal speech. Specialist perceptual assessment and dynamic imaging or endoscopy during speech establish whether abnormal resonance reflects inadequate velopharyngeal closure. The closure pattern and gap inform anatomical planning, while airway assessment identifies an important competing risk. Structural dysfunction supports consideration of surgery or a prosthesis; an isolated learned articulation error does not establish an anatomical target.
Apply it
Persistent hypernasality accompanies a demonstrated gap during speech. Plan individualized structural treatment while assessing airway risk. Adequate closure with phoneme-specific errors instead supports a speech-therapy approach.
Common pitfall: Selecting an operation from voice quality alone can miss the mechanism. Improving closure and preserving airway function must both inform the treatment plan.
19.How should articulation therapy be coordinated with structural correction?
Speech therapy treats compensatory articulation and velopharyngeal mislearning; it cannot close a structural gap. When both mechanisms are present, therapy and structural treatment have separate targets. After correction, persistent glottal substitutions may still require therapy despite improved resonance. Persistent generalized hypernasality or nasal emission warrants reassessment of closure rather than assuming every remaining difference is learned. Nonspeech blowing exercises do not provide definitive treatment of structural velopharyngeal dysfunction.
Apply it
After surgery, resonance improves but glottal stops persist and closure is adequate on reassessment. Choose specialist articulation therapy. Renew structural investigation if generalized hypernasality returns or testing demonstrates a residual gap.
Common pitfall: Residual articulation errors alone do not prove surgical failure. Continued abnormal resonance also should not automatically be attributed to habit without evaluating closure.
20.How is confirmed pressure-ulcer osteomyelitis treated?
Confirmed osteomyelitis beneath a pressure ulcer requires a plan for infected bone and its microbiology. WHS supports adequate debridement and culture-guided antibiotics, with vascularized flap reconstruction for appropriately selected patients. Debridement addresses devitalized infected tissue, targeted therapy addresses the organism, and reconstruction provides coverage. Suitability for reconstruction remains a patient-level decision rather than an automatic consequence of diagnosis, particularly when postoperative pressure relief cannot be delivered.
Apply it
Bone histology and culture confirm osteomyelitis beneath a sacral ulcer. Select debridement and organism-directed antibiotics within a coordinated coverage plan. Defer definitive closure if infection control or postoperative pressure management remains inadequate.
Common pitfall: Covering infected devitalized bone can conceal rather than resolve the problem. Antibiotics or a technically successful flap alone do not supply every component of treatment.
WHS Guidelines for the Treatment of Pressure Ulcers—2023 Update
Intraoperative or Early Postoperative Complicationsnot stated
21.Why can compartment syndrome occur with palpable pulses?
Compartment syndrome threatens microvascular perfusion as pressure rises inside a closed fascial space. A distal arterial pulse can remain detectable while muscle and nerve capillary flow is compromised. Progressive pain, increasing analgesic requirements, tense swelling, and pain with passive stretch therefore outweigh reassurance from pulse presence. Recognize the evolving tissue-perfusion emergency early rather than waiting for a late sign of severe arterial compromise.
Apply it
After leg trauma, a patient develops escalating pain, tense swelling, and pain with passive toe movement despite palpable foot pulses. Treat the pattern as concerning for compartment syndrome and escalate assessment immediately.
Common pitfall: Waiting for pulselessness substitutes a late arterial finding for assessment of muscle perfusion. A warm foot or detectable pulse does not resolve the compartment question.
22.How is compartment perfusion pressure calculated and interpreted?
Subtract intracompartmental pressure from concurrently measured diastolic blood pressure. The July 2025 UK BOASt standard identifies a difference below 30 mmHg as increased risk requiring consultant orthopaedic decisions about decompression or continued monitoring. This is a risk criterion rather than an automatic diagnosis from one reading. When findings are inconclusive, repeat documented examinations and consider monitoring all suspected compartments. Once compartment syndrome is diagnosed, immediate surgical decompression is required.
Apply it
Diastolic pressure of 58 mmHg and compartment pressure of 40 mmHg produce an 18-mmHg difference. In an obtunded patient, this supports urgent senior assessment and appropriate monitoring or decompression according to the complete evaluation.
Common pitfall: Using systolic pressure gives the wrong calculation. Hypotension can worsen perfusion without increasing compartment pressure, and a reassuring isolated measurement cannot override convincing clinical deterioration.
BOASt - Diagnosis and Management of Compartment Syndrome of the Extremities · AO Surgery Reference: Compartment Syndrome in the Leg
23.When should fasciotomy proceed without pressure measurement?
A convincing clinical diagnosis of acute compartment syndrome requires emergency decompression. Pressure measurement is useful when diagnosis is uncertain or examination is unreliable; it should not become a barrier when the syndrome is clinically established. Decompression addresses the mechanism by releasing constraining fascia. Serial observation is appropriate for an at-risk limb only while compatible with the findings and must not postpone treatment of an established emergency.
Apply it
An alert patient develops rapidly progressive pain, tense compartments, passive-stretch pain, and new sensory change after a crush injury. Activate emergency decompression rather than delaying a clear diagnosis while locating measurement equipment.
Common pitfall: Treating measurement as mandatory in every case can delay rescue. Testing is useful when it improves the decision without postponing necessary treatment.
AO Surgery Reference: Compartment Syndrome in the Leg · BOASt - Diagnosis and Management of Compartment Syndrome of the Extremities
24.Which findings distinguish free-flap inflow and outflow problems?
Interpret colour, temperature, refill, turgor, bleeding characteristics, and Doppler findings together against the postoperative baseline. A pale, cool flap with poor refill suggests impaired inflow. A blue-purple, swollen flap suggests impaired outflow, particularly with brisk dark bleeding. Preserved arterial flow cannot establish adequate venous drainage. The practical decision is to escalate a meaningful deterioration promptly while identifying whether compression, hematoma, or a vascular problem may require exploration.
Apply it
A previously normal flap becomes blue and tense despite an arterial Doppler signal. Escalate suspected outflow obstruction rather than treating that signal as proof of adequate overall circulation.
Common pitfall: No single monitoring sign replaces the clinical pattern. The older observational free-flap study supports prompt rescue but does not establish a safe waiting interval.
Bui et al.: Free Flap Reexploration—Indications, Treatment, and Outcomes in 1193 Free Flaps, 2007
25.How should exploration address suspected free-flap compromise?
Urgently mobilize surgical assessment and exploration when significant vascular compromise persists. Correct immediately identifiable external compression or positioning problems while preparing rescue. Exploration can identify hematoma, pedicle obstruction, or thrombosis and permit cause-directed treatment. Bui's 2007 observational series identified pedicle thrombosis and hematoma or bleeding among important reexploration causes. Its findings support timely recognition and rescue rather than a mandatory numerical deadline or permission to observe progressive compromise.
Apply it
Congestion persists after a tight dressing is released. Arrange urgent exploration for a correctable cause rather than relying on continued observation or a nonsurgical adjunct as the initial substitute.
Common pitfall: A quoted salvage window does not justify delay. Temporary improvement in one sign also does not establish that the underlying vascular problem has resolved.
Bui et al.: Free Flap Reexploration—Indications, Treatment, and Outcomes in 1193 Free Flaps, 2007
26.Which findings suggest filler-related vascular injury?
Unusual pain, blanching, visual change, or stroke-like symptoms during or shortly after filler injection suggest possible entry into a blood vessel. Vascular obstruction can injure skin or structures distant from the injection site. Stop injecting and initiate urgent assessment and management. Continuing product placement to complete symmetry increases exposure to the suspected mechanism and delays recognition of an injury that may have permanent consequences.
Apply it
During facial filler injection, sudden severe pain accompanies skin blanching. Stop immediately, assess for visual and neurological symptoms, and activate the vascular-complication response without completing the planned treatment.
Common pitfall: Marked pain and blanching do not fit routine bruising. Absence of visual symptoms does not make the cutaneous vascular warning pattern benign or justify continued injection.
27.Why is visual change during filler injection an emergency?
Visual change during filler injection raises concern for a vascular complication with potentially permanent consequences, including blindness. It requires immediate cessation and emergency medical evaluation. A benign skin appearance does not exclude a serious event affecting another vascular territory. Communicate the symptom, exact onset, product, injection site, and procedural details clearly so that transfer of care supports rapid assessment rather than treating the event as routine postoperative discomfort.
Apply it
A patient develops blurred vision during central facial injection without dramatic skin discoloration. Stop the procedure and arrange immediate emergency assessment, communicating symptom onset and the relevant injection details.
Common pitfall: Waiting for cutaneous necrosis before escalating misunderstands the risk. Visual symptoms demand emergency action even when the injection site appears relatively unremarkable.
28.Which postoperative findings suggest a necrotizing infection?
An aggressive postoperative infection with systemic toxicity requires assessment for a deep destructive process. Rapid progression, severe pain, firm induration, and worsening general condition increase concern. The decision rests on the whole pattern because early external changes can underestimate disease extent. IDSA's 2014 guideline supports prompt surgical consultation when necrotizing infection is suspected. A modest-looking incision does not justify waiting for advanced skin destruction or obvious gas.
Apply it
Rapidly worsening pain, spreading swelling, confusion, and tachycardia outweigh limited visible erythema. Select urgent surgical assessment over routine cellulitis management. Hypotension strengthens the need for simultaneous resuscitation and emergency source control.
Common pitfall: A small skin abnormality can coexist with extensive deeper disease. Waiting for gangrene or gas may postpone treatment until substantial tissue injury has occurred.
29.How should suspected necrotizing infection be treated initially?
Begin resuscitation and urgent surgical source control concurrently with broad intravenous antibiotics covering MRSA, gram-negative organisms, and anaerobes. IDSA gives vancomycin plus piperacillin-tazobactam as an empiric example; adjust selection and dosing for allergies, renal function, exposure history, and local susceptibility. Documented group A streptococcal necrotizing infection is treated with penicillin plus clindamycin, which contributes suppression of toxin production. Cultures and imaging must not postpone necessary debridement.
Apply it
A hypotensive postoperative patient receives resuscitation, broad empiric antibiotics, and emergency operative assessment. If deep specimens establish group A streptococcus, change to penicillin plus clindamycin while continuing appropriate source control.
Common pitfall: Vancomycin alone lacks the required gram-negative and anaerobic coverage. A targeted streptococcal regimen should not replace broad empiric treatment before the cause is established.
30.How should an unexpected postoperative course change the working diagnosis?
A postoperative explanation must remain consistent with the patient's trajectory. When pain, function, physiology, or wound findings diverge from the expected course, reassess the diagnosis and identify reversible threats before defending the original plan. ABPS emphasizes judgment, complication management, and alternative rescue plans. State what changed, why the original explanation is insufficient, and which immediate assessment follows. The urgency depends on the new findings rather than the earlier discharge decision.
Apply it
A patient awaiting discharge develops escalating pain and new functional loss. Cancel discharge, obtain an immediate focused examination, compare with baseline, and select the rescue pathway supported by the findings.
Common pitfall: Attachment to the first explanation can turn new evidence into an inconvenience. An earlier reassuring examination does not invalidate later clinically meaningful deterioration.
Late Complicationsnot stated
31.When should late peri-implant swelling prompt lymphoma evaluation?
Persistent swelling, a peri-implant mass, or pain appearing well after implantation requires assessment for causes including BIA-ALCL. This is a lymphoma associated with the implant environment. A late fluid collection should not automatically be labelled a routine postoperative seroma. Obtain a diagnostic evaluation before selecting a revision operation because confirmation changes the purpose and extent of surgery. The symptom-free interval does not exclude a newly important implant-associated disorder.
Apply it
Eight years after augmentation, progressive unilateral enlargement and peri-implant fluid prompt imaging and appropriate fluid or tissue assessment before elective exchange. Confirmed lymphoma changes the operation to an oncologic treatment plan.
Common pitfall: Draining fluid for comfort without a diagnostic plan can discard essential information. Long uncomplicated implant use does not establish that a new collection is benign.
32.Which specimens are needed when BIA-ALCL is suspected?
Evaluation requires pathological assessment of relevant peri-implant material. FDA identifies fresh seroma fluid and representative capsule tissue, with cytological evaluation and appropriate CD30 and ALK testing. Disease may involve fluid or capsule rather than breast parenchyma. Communicate the specific concern to pathology so that a routine culture-only request does not replace lymphoma-focused assessment. Specimen selection should address the suspected disease rather than merely collect whatever tissue is most convenient.
Apply it
A patient has a new late seroma and capsular abnormality. Coordinate fluid and representative tissue assessment with pathology, explicitly identifying concern for BIA-ALCL and the required diagnostic studies.
Common pitfall: A negative bacterial culture does not exclude lymphoma. Sampling only breast tissue or discarding seroma fluid can omit the material most relevant to diagnosis.
33.How should implant texture influence BIA-ALCL counseling?
FDA identifies higher BIA-ALCL risk with textured than smooth implant surfaces. Surface-related risk should be distinguished from saline-versus-silicone fill. For asymptomatic patients, FDA does not recommend routine removal solely because of BIA-ALCL concern. Explain the association, symptoms requiring assessment, and individualized choices without converting comparative risk into certainty of cancer. Elective removal remains a separate preference-sensitive decision that includes operative risks and expectations.
Apply it
An asymptomatic patient with textured implants prefers avoiding another operation. Discuss continued observation with symptom education and explain removal options. New swelling, pain, or a mass changes the task to diagnostic evaluation.
Common pitfall: Confusing fill with surface texture misstates the evidence. Automatic surgery for every asymptomatic patient overlooks the separate risks and preferences involved in removal.
34.How is capsular contracture distinguished by severity?
Capsular contracture produces tightening around an implant, with increasing firmness, distortion, and sometimes pain. Baker grade II describes some firmness with normal appearance; grade III adds abnormal appearance; grade IV includes hardness, pain, and abnormal appearance. Severe contracture may require reoperation and can recur after correction. Explain the symptom and deformity burden while evaluating accompanying late changes that may require a separate diagnostic pathway before revision.
Apply it
A patient has a hard, painful, visibly distorted augmented breast. Recognize severe contracture, assess the full late-change history, and discuss revision with explicit counseling that another operation cannot eliminate recurrence risk.
Common pitfall: Firmness alone is not equivalent to painful deforming contracture. New swelling or a mass should not be dismissed because capsular tightening is also present.
35.Why can silicone implant rupture be clinically silent?
Silicone gel may remain within the fibrous capsule after shell failure, preserving apparent shape and volume. Examination therefore cannot reliably exclude rupture. FDA labeling recommends ultrasound or MRI for asymptomatic silicone implants beginning 5–6 years after implantation and every 2–3 years thereafter. MRI is recommended for symptoms suggesting rupture or equivocal ultrasound at any postoperative time. These are clinical labeling recommendations rather than ABPS examination rules.
Apply it
An asymptomatic patient six years after implantation has a normal examination and no prior integrity imaging. Arrange ultrasound or MRI now. After a normal study, plan repeat imaging in 2–3 years; equivocal ultrasound supports MRI.
Common pitfall: Silicone rupture need not resemble saline deflation. Implant-integrity imaging also does not replace breast-cancer screening appropriate to the patient's age and risk.
36.How should late implant problems shape revision expectations?
Breast implants are not lifetime devices, and complication likelihood increases with time. Revision may address pain, rupture, displacement, contracture, or aesthetic dissatisfaction, but another operation cannot guarantee a satisfactory cosmetic result. Removal without replacement can leave contour changes. Explain the specific problem being treated and distinguish medically indicated management from optional aesthetic changes, including the possibility that residual deformity or future procedures remain part of the outcome.
Apply it
A patient requesting removal expects the breasts to return automatically to their preimplant appearance. Explain possible contour changes and compare removal alone, replacement, and other appropriate reconstructive choices.
Common pitfall: Describing revision as a permanent reset creates unrealistic expectations. Treating one complication does not guarantee ideal contour, freedom from further surgery, or restoration of original anatomy.
37.How should delayed filler nodules be distinguished from an acute vascular event?
Filler complications can appear weeks, months, or years after treatment. Delayed nodules or inflammation require assessment for inflammatory reactions, granulomas, or infection rather than automatic application of an acute intravascular-injection diagnosis. Establish the product, injection sites, timing, and associated symptoms before choosing treatment. Sudden pain, blanching, or visual change during injection follows an emergency vascular pathway; a delayed lump has a different diagnostic starting point.
Apply it
Months after treatment, persistent localized nodules develop without an acute injection-related event. Obtain the product history and assess inflammation or infection before treatment. Rapid progression or systemic illness increases urgency.
Common pitfall: Timing frames the differential but does not prove the cause. A delayed nodule should not be dismissed as expected immediate swelling or treated without product information.
Complications/Outcomenot stated
38.How should support surfaces and repositioning prevent pressure-wound recurrence?
Pressure redistribution requires an appropriate support surface and a feasible individualized repositioning schedule. Match equipment to mobility, shear, and microclimate needs, then verify that the injured site is actually unloaded. WHS advises avoiding direct positioning on ulcers and vulnerable prominences. A mattress cannot replace repositioning, and a written schedule cannot establish that caregivers can implement it. Assess the real loading pattern when judging whether closure can remain durable.
Apply it
Sacral breakdown recurs despite a new mattress because the patient remains directly supine for prolonged periods. Correct positioning and caregiver support before attributing failure to the dressing or flap.
Common pitfall: A product label does not demonstrate effective offloading. Repeating reconstruction without changing sustained loading can reproduce the original injury despite technically successful surgery.
WHS Guidelines for the Treatment of Pressure Ulcers—2023 Update
39.When should pressure-wound flap reconstruction be deferred?
Readiness for closure depends on conditions that permit reconstruction to survive. Infection management, wound preparation, patient condition, and a workable pressure-relief plan must support the operation. Availability of a flap does not establish that immediate closure offers durable benefit. When essential postoperative care cannot be delivered, continue appropriate wound management while correcting the limitation and reassessing candidacy. Deferral should identify an achievable clinical or practical goal.
Apply it
A clean ischial wound is coverable, but the patient cannot reposition and lacks assistance. Defer elective closure while establishing feasible offloading. Reliable care would remove that barrier and permit renewed assessment.
Common pitfall: Selecting a larger flap cannot substitute for postoperative pressure relief. Merely recording poor candidacy also fails to address the conditions that prevent healing.
WHS Guidelines for the Treatment of Pressure Ulcers—2023 Update
40.How should recurrence despite effective offloading change the investigation?
A recurrent wound can reflect mechanical loading, unresolved infection, or another impediment to healing. Verify the proposed explanation against observed care and wound findings. When offloading is demonstrably adequate but a deep wound persists or reopens over bone, reconsider osteomyelitis rather than assuming a different flap will solve the problem. WHS recommends bone histology and culture when osteomyelitis is suspected. Investigation should test the mechanism suggested by current evidence.
Apply it
A deep recurrent sacral wound exposes bone despite documented pressure relief. Investigate possible bone infection before immediate repeat coverage. If infection is excluded and renewed loading is identified, address that demonstrated cause.
Common pitfall: Neither infection nor pressure is an automatic explanation. An unchanged assumption can lead to repeated treatment that never addresses the actual recurrence mechanism.
WHS Guidelines for the Treatment of Pressure Ulcers—2023 Update
41.Which findings demonstrate a meaningful hand-surgery outcome?
A healed incision documents wound closure but does not establish recovery of hand function. ABPS asks candidates to demonstrate preoperative limitation and postoperative functional restoration in hand cases. Compare the function relevant to the original problem with the later condition. Explain residual limitations honestly and use clinical observations and photographs that answer the functional question. Symptom relief, movement, and relevant daily tasks may reveal different aspects of recovery.
Apply it
A case report contains only a photograph of a healed palm. Add documentation comparing the presenting functional limitation with postoperative hand use, symptoms, and any persisting impairment at follow-up.
Common pitfall: An attractive scar can distract from incomplete recovery. Do not equate wound healing with symptom resolution, restored movement, or return to the patient's relevant activities.
ABPS 2025–2026 Booklet of Information: Oral Examination Section
42.How should temporary benefit from a carpal tunnel injection be interpreted?
Short-term symptom improvement and durable benefit are different outcomes. AAOS 2024 concludes that corticosteroid injection does not provide long-term improvement in CTS. An early favourable response should not be presented as evidence of permanent resolution. Recurrent symptoms require renewed assessment of the current pattern and discussion of options according to severity, function, and patient preferences. The previous response supplies clinical history but does not establish the cause of every later symptom.
Apply it
Nocturnal symptoms improve after injection but later recur and interfere with daily tasks. Reassess the CTS findings and discuss further care. A changed distribution or discordant examination warrants diagnostic clarification before surgery.
Common pitfall: Do not promise durable control from an early response. Recurrence also does not establish that every current symptom has the same localization or mechanism.
AAOS: Management of Carpal Tunnel Syndrome Evidence-Based Clinical Practice Guideline, 2024
43.How should residual aesthetic differences be discussed?
Outcome assessment should separate the goal achieved from the limitation remaining. Symmetry in clothing, contour, wound healing, tissue quality, and patient concerns describe different dimensions of a result. ABPS requires a separate outcome paragraph stating the final condition. Explain the observed difference and its relevance without claiming perfection or assuming that every residual difference requires another operation. Further treatment should be considered against patient goals and acceptable burdens.
Apply it
After reconstruction, breast volume is reasonably matched but one breast remains more elevated. Describe both achieved symmetry and residual contour difference, then discuss whether further treatment fits the patient's priorities.
Common pitfall: Calling a result satisfactory without specifying limitations prevents meaningful evaluation. A photograph alone cannot establish how the patient experiences the difference or values further intervention.
ABPS 2025–2026 Booklet of Information: Oral Examination Section
Safetynot stated
44.When does burn extent or depth warrant immediate consultation?
ABA distinguishes immediate consultation with consideration for transfer from a consultation recommendation. Full-thickness injury and partial-thickness injury involving at least 10% TBSA enter the immediate category. Partial-thickness burns below 10% and potentially deep burns of any size also warrant consultation. Identify depth, size, and other referral features before selecting the category. Specialist communication accompanies appropriate stabilization and does not require withholding necessary local emergency care.
Apply it
An adult has 12% partial-thickness injury after superficial erythema is excluded. Select immediate burn-centre consultation with consideration for transfer. An uncomplicated 6% superficial partial-thickness injury outside critical sites has a different size-based category.
Common pitfall: The 10% threshold applies to partial-thickness extent. Full-thickness injury does not need to reach 10% to enter the immediate-consultation category.
American Burn Association: Guidelines for Burn Patient Referral
45.Why can a small burn require immediate specialist consultation?
TBSA alone does not determine referral urgency. ABA places deep partial-thickness or full-thickness burns involving the face, hands, feet, genitalia, perineum, or skin over joints in the immediate-consultation category with consideration for transfer. Uncertainty about a potentially deep burn of any size warrants consultation. Distinguish demonstrated deep injury at a critical site from an area estimate or uncertain depth assessment, and document the findings supporting that distinction.
Apply it
A pale, poorly blanching deep partial-thickness burn crosses finger joints but occupies 1% TBSA. Choose immediate consultation with consideration for transfer because depth and location independently meet the category.
Common pitfall: Hand location alone does not establish depth. Record appearance, blanching, moisture, and sensation rather than assigning urgency from an anatomical label without examination.
American Burn Association: Guidelines for Burn Patient Referral
46.Which burn mechanisms change the referral decision?
Mechanism adds risk that a skin-area estimate cannot capture. ABA recommends immediate consultation with consideration for transfer for suspected inhalation injury, chemical injury, high-voltage electrical injury, and lightning injury. A limited external wound cannot settle disposition. Explain the exposure history and associated symptoms when contacting the specialist service because the referral question includes possible injury beyond visibly burned skin. Mechanism and examination must both inform the assessment.
Apply it
A worker has a small visible wound after high-voltage electrical exposure. Arrange immediate specialist consultation and consideration of transfer rather than classifying the whole injury as minor from its cutaneous area.
Common pitfall: Visible wound size can underrepresent mechanism-related risk. A superficial-looking finding should not override an exposure history that independently supports urgent specialist assessment.
American Burn Association: Guidelines for Burn Patient Referral
47.How should implant surveillance differ from symptom evaluation?
For asymptomatic silicone implants, FDA labeling recommends ultrasound or MRI at 5–6 years and every 2–3 years thereafter. Symptoms suggesting rupture or equivocal ultrasound support MRI at any time. A new mass or seroma requires its own diagnostic pathway, potentially including targeted imaging and fluid or tissue assessment. Surveillance evaluates implant integrity in an asymptomatic setting; a new symptom changes the clinical question and may require different specimens.
Apply it
A normal integrity study at year six supports repeat surveillance at year eight or nine. New unilateral swelling at year seven requires evaluation now. Equivocal ultrasound for rupture additionally supports MRI.
Common pitfall: A normal shell-integrity study does not exclude every cause of a mass or collection. Routine surveillance intervals must not delay assessment of new symptoms.
48.How should outpatient deterioration trigger hospital-level rescue?
A safe outpatient plan anticipates needs exceeding the facility's capabilities and identifies how clinical responsibility continues during transfer. Connect new findings to immediate assessment, available stabilization, and an appropriate receiving service. A transfer destination alone does not establish that the route can be activated or relevant information will accompany the patient. Escalation depends on current patient needs and actual local capability rather than previous uncomplicated experience with the procedure.
Apply it
A postoperative patient deteriorates beyond a freestanding facility's capabilities. Activate emergency transfer, communicate the operation, timeline, findings, and treatment, and arrange continued surgical involvement.
Common pitfall: A hospital address or generic telephone number is insufficient evidence of a workable rescue plan. Unclear ownership during transfer can interrupt assessment and treatment.
ABPS 2025–2026 Booklet of Information: Oral Examination Section
49.How does postoperative continuity support patient safety?
Postoperative care remains part of the operating surgeon's responsibility and should not be fully delegated away. ABPS emphasizes an appropriate physician-patient relationship and continued surgeon involvement. Continuity allows the clinician who understands the original problem and operative choices to interpret unexpected findings and explain management changes. Identify who reviews the patient, how concerns reach the surgeon, and how in-person assessment occurs when needed. The arrangement should be established before elective treatment.
Apply it
A patient will recover away from the operating facility. Establish follow-up, escalation, and surgeon involvement before proceeding rather than relying entirely on an unspecified external postoperative service.
Common pitfall: Providing a contact number does not establish continuity. The pathway must connect evolving symptoms to someone able to assess the operation and act appropriately.
ABPS 2025–2026 Booklet of Information: Oral Examination Section
Ethics/Professionalismnot stated
50.What makes consent an informed decision?
Consent requires a patient who can understand relevant information and make a voluntary decision. AMA identifies discussion of diagnosis, purpose, expected benefits, burdens, risks, and alternatives, including forgoing treatment. The decisive evidence is an understandable exchange supporting authorization rather than possession of a signature alone. Explain what the patient needed to decide and how the discussion addressed the options relevant to that decision. Clarify misunderstandings before proceeding with elective intervention.
Apply it
A patient signs a standard form but cannot explain the proposed benefit or alternatives. Pause to clarify understanding before treating the signature as sufficient authorization.
Common pitfall: A form can document consent without creating understanding. Rapidly listing risks is inadequate if the patient cannot connect the information to the actual decision.
51.Why can preoperative commitments undermine voluntariness?
Payments, arranged leave, travel, and postoperative commitments can make cancellation feel difficult despite unresolved concerns. ABPS expects the physician-patient relationship for nonemergent surgery to be established in person before the operative day, with specified exceptions. The ethical mechanism is pressure on free deliberation. Address substantive concerns before commitments dominate the decision and preserve a meaningful opportunity to reconsider. Logistical inconvenience does not resolve unanswered questions about benefits, alternatives, or risks.
Apply it
At the first surgeon encounter on the elective operative day, the patient remains uncertain but fears losing a deposit. Defer proceeding until examination, understanding, and voluntary deliberation are adequate.
Common pitfall: Reluctance to lose a deposit is not evidence of informed preference for surgery. Urgent reconstructive circumstances alter timing considerations but do not remove the need for appropriate consent.
ABPS 2025–2026 Booklet of Information: Oral Examination Section
52.How should an informed decision to decline treatment be documented?
A patient with decision-making capacity may choose an option the surgeon would not prefer, including forgoing treatment. Document the discussion, understanding, and decision while explaining follow-up and consequences. AMA's consent framework includes alternatives and no treatment because authorization must remain voluntary. Disagreement is an occasion to clarify information and values rather than assume incapacity. The record should describe the actual exchange rather than apply a dismissive label that obscures the patient's reasoning.
Apply it
A patient understands reconstruction and its alternatives but declines because recovery conflicts with personal priorities. Document the informed choice and agree on follow-up and reasons to return.
Common pitfall: Disagreement alone does not establish incapacity. Recording only that the patient was noncompliant fails to describe information provided, understanding, and voluntary choice.
53.How should permission for case photographs be handled?
Permission to perform surgery does not establish permission for every later use of records and images. ABPS requires consent for examination, testing, credentialing, or certification use and expects protection of identifying information. Preserve both permission and confidentiality. Explain the intended use, retain original authorization, and present de-identified material without changing the features demonstrating the result. Image preparation must protect identity while preserving the clinical truth of the case.
Apply it
A selected case has operative consent but lacks authorization for certification use of records and photographs. Address the missing permission and confidentiality requirements before considering the materials ready for presentation.
Common pitfall: Removing a name does not supply missing permission. Obtaining permission also does not eliminate the obligation to protect identifiers in submitted records and images.
ABPS 2025–2026 Booklet of Information: Oral Examination Section
54.How should later additions to a clinical record be disclosed?
A later clarification must remain distinguishable from the contemporaneous record. ABPS requires disclosure of edits or appended notes made after notification of selected cases and may review revision history. This protects the chronology on which management is judged. Identify additions transparently and preserve original documentation rather than rewriting the course to make earlier reasoning appear more complete. Accuracy of content and accuracy of documentary timing are separate professional obligations.
Apply it
After case selection, an important discussion appears poorly documented. Preserve the original note, make any appropriate later clarification transparently, and disclose the change instead of silently replacing the entry.
Common pitfall: A plausible recollection does not become contemporaneous documentation through backdating. Improving readability must not obscure when information was recorded or what the original contained.
ABPS 2025–2026 Booklet of Information: Oral Examination Section
Case Report Preparation/Organizationnot stated
55.How should a narrative summary explain clinical reasoning?
A useful narrative connects the presenting problem, management choice, operative course, complications, and final condition. Explain why events led to later decisions rather than merely listing procedures. ABPS requires a separate outcome paragraph and inclusion of issues requiring more than ordinary management. This organization lets the examiner follow the clinical trajectory and judgment without inferring causal links from scattered records. Include both inpatient and outpatient treatment burdens when relevant.
Apply it
A reconstruction requires prolonged wound care and later revision. Explain the original choice, the problem that developed, the reason for additional treatment, and the final condition in a separate outcome paragraph.
Common pitfall: A polished procedure list can conceal the decision sequence. Excessive brevity is harmful when it removes the reason for an intervention or the burden of recovery.
ABPS 2025–2026 Booklet of Information: Oral Examination Section
56.Why should operative records follow the patient's chronology?
Chronological organization shows what information and authorization preceded each procedure and how management evolved. ABPS directs candidates to place relevant operative consent before each report and include all candidate-performed procedures within the collection period for the selected patient. A later operation may represent planned staging or treatment of a complication. Clear sequencing distinguishes those reasons and connects each intervention to the clinical circumstances that justified it.
Apply it
A patient undergoes reconstruction, office debridement, and revision during the collection period. Present each procedure in order with its relevant consent and explain whether it was planned or prompted by an adverse event.
Common pitfall: Grouping documents around the most successful operation can distort the course. A minor office procedure may still provide essential evidence of complication management.
ABPS 2025–2026 Booklet of Information: Oral Examination Section
57.How should adverse events and successful salvage be reported together?
Describe the complication, recognition, additional treatment, and final outcome separately. ABPS reporting extends beyond catastrophic morbidity to oral antibiotics, prolonged dressings, extra consultations, and other care exceeding the ordinary course. Successful rescue does not erase an unplanned operation, debridement, or treatment burden. An inclusive chronology permits evaluation of the adverse event and the judgment that produced salvage. Final healing and an uncomplicated recovery are different statements.
Apply it
A flap survives after urgent reexploration, office debridement, and extended dressings. Record every event and its reason, then state final coverage and function as successful salvage after complications.
Common pitfall: Reporting only final success removes evidence needed to assess rescue decisions. Resolution does not make an adverse event irrelevant or justify omitting additional care.
ABPS 2025–2026 Booklet of Information: Oral Examination Section
58.How should images demonstrate the operation's key mechanism?
Photographs must demonstrate the original problem, key procedure, and later result. For a flap, show the defect and raised flap; for reduction mammaplasty, the reduced pedicle supporting the nipple–areolar complex; for fixation, the reduced fracture and applied hardware. The 2026 handbook excludes end-of-case closed-incision photographs from satisfying the intraoperative requirement. A written operative report explains the procedure but does not replace mandatory images demonstrating its key component.
Apply it
A flap case includes preoperative and final images but only a closed-incision operating-room photograph. Identify the missing defect and raised-flap views instead of treating a longer narrative as an equivalent substitute.
Common pitfall: A finished incision does not demonstrate the operative step. Clinical clarity and compliance with required photographic evidence must both be assessed.
ABPS 2025–2026 Booklet of Information: Oral Examination Section
59.How should investigations support the case argument?
Investigations belong in a case because they explain diagnosis, risk, a management choice, or an outcome. ABPS asks for pertinent laboratory, pathological, and radiological material organized chronologically, with imaging reports adjacent to corresponding images. Highlight the finding that changed the plan while retaining enough context for interpretation. This makes evidence assessable without burying the decisive result among unrelated normal findings. Selectivity should improve clinical clarity while preserving essential information.
Apply it
A report includes extensive routine laboratories but omits pathology determining definitive excision. Reorganize the evidence around diagnostic and treatment decisions, with dated reports and relevant images placed together.
Common pitfall: Document volume is not evidentiary completeness. Omitting one decisive report can weaken a case more than adding many normal results can strengthen it.
ABPS 2025–2026 Booklet of Information: Oral Examination Section
60.How should alternatives and rescue plans be defended?
A defensible presentation identifies why treatment fit the patient, which reasonable alternatives existed, and how foreseeable failure would be managed. ABPS emphasizes procedural choices and alternative rescue plans. Use information available at the time rather than relying on the eventual result. State the finding that would trigger change, the next practical action, and the goal of rescue. An alternative becomes meaningful when its indications and trade-offs are explained.
Apply it
For a reconstruction, present the original findings, selected operation, and reasonable alternative. Explain the patient-specific goal, then identify a postoperative finding that would trigger reassessment and the corresponding rescue action.
Common pitfall: A good final result does not validate every earlier choice. Naming alternatives without explaining when or why they become preferable leaves the reasoning incomplete.
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Distinguish diagnostic evidence from staging information in melanoma, hand neuropathy, and pressure-ulcer osteomyelitis.
- Defend operations through patient-specific goals, alternatives, expected benefit, and reconstructive consequences.
- Connect concrete tissue-threatening findings to the suspected mechanism and required rescue action.
- Apply compartment perfusion criteria, antimicrobial coverage, and silicone surveillance intervals with their limitations.
- Separate late implant rupture, contracture, and suspicious peri-implant changes before recommending revision.
- Assess function, residual limitations, recurrence mechanisms, and treatment burden alongside final appearance.
- Demonstrate voluntary consent, continuity of care, honest records, and transparent adverse-event reporting.
- Use the official oral assessment outline as the full scope and extend preparation beyond these selected concepts.
A practical preparation plan
1. Map the clinical decision
State the problem, decisive findings, missing information, reasonable alternatives, and preferred plan. Explain why one new finding would change that plan.
2. Rehearse emergency transitions
Connect compartment, flap, filler, and infection findings to the mechanism, immediate assessment, and rescue action. Explain when testing resolves uncertainty and when it would delay established emergency treatment.
3. Defend each selected case
Reconstruct the chronology through every additional procedure. Identify evidence supporting the original choice, complications encountered, and reasons for subsequent management.
4. Audit outcomes and consent
Compare initial goals with the final condition, including function and residual differences. Check that alternatives, patient decisions, additional care, and record changes are described transparently.
5. Use the drills aloud
Explain the decisive cue and reject each alternative using its option text. Use flashcards for recall and revisit the underlying concept whenever the reasoning remains uncertain.
6. Expand against official scope
Review the applicable ABPS handbook and examination guidance alongside your case mix. Add cases in areas absent from this selective guide and rehearse alternative treatment and rescue strategies.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- ABPS: Overview of Oral Exam
- ABPS: Publications & Requirements
- ABPS 2025–2026 Booklet of Information: Oral Examination Section
- ABPS Booklet of Information: July 1, 2026–June 30, 2027
- ABPS: Preparation for Examinations
- FDA: Questions and Answers about BIA-ALCL
- FDA: Risks and Complications of Breast Implants
- American Burn Association: Guidelines for Burn Patient Referral
- American Burn Association: Burn Patient Referral Guidelines, 2022
- AAOS: Management of Carpal Tunnel Syndrome Evidence-Based Clinical Practice Guideline, 2024
- AO Surgery Reference: Compartment Syndrome in the Leg
- National Cancer Institute: Melanoma Treatment (PDQ), Health Professional Version
- ACPA: Parameters of Care, 2024
- British Orthopaedic Association: BOASt—Open Fractures
- FDA: Dermal Fillers (Soft Tissue Fillers)
- IDSA: Skin and Soft Tissue Infection Guideline, 2014
- Bui et al.: Free Flap Reexploration—Indications, Treatment, and Outcomes in 1193 Free Flaps, 2007
- Wound Healing Society: Clinical Practice Guidelines and Tools
- WHS Guidelines for the Treatment of Pressure Ulcers—2023 Update
- AMA Code of Medical Ethics: Informed Consent, Opinion 2.1.1
- BOASt - Diagnosis and Management of Compartment Syndrome of the Extremities
- download
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.